Abstract

This study delves into the bioactive potential of imidazole derivatives, focusing on their synthesis, characterization, and applications in medicinal chemistry. Imidazole, a five-membered heterocyclic compound, serves as a core structure in various bioactive compounds exhibiting antimicrobial, anticancer, anti-inflammatory, and antidiabetic properties. This study aims to review the most recent methods for synthesizing imidazole derivatives, characterize their chemical properties, and explore their biological activities. The importance of structure-activity relationships (SAR) is emphasized to guide future drug design efforts involving imidazole-based compounds.

References

1. Bhatnagar, A., Sharma, P. K., Kumar, N., & Dudhe, R. (2011). A review on imidazoles: Their chemistry and pharmacological potentials. International Journal of PharmTech Research, 3(1), 268–282.
2. Chen, T.-C., Chang, C.-Y., Tseng, C.-H., Wang, J.-Y., Hsu, M.-H., & Chang, C.-F. (2013). Structure-based design, synthesis and biological evaluation of novel anthra[1,2-d]imidazole-6,11-dione homologues as potential antitumor agents. European Journal of Medicinal Chemistry, 69, 278–293. https://doi.org/10.1016/j.ejmech.2013.08.022
3. Devi, M., Devi, K., Mukherjee Singh, O., & Singh, T. (2024). Synthesis of imidazole derivatives in the last 5 years: An update. Heterocyclic Communications, 30(1). https://doi.org/10.1515/hc-2022-0173
4. Farh, I. (2016). Synthesis and characterization of some imidazole derivatives. International Journal of Engineering & Technology Sciences, 3, 34–42.
5. Gobis, K., Holý, P., Pindjaková, L., Waisser, K., Kaustová, J., Klimešová, V., & Miletín, M. (2015). Novel 2-(2-phenalkyl)-1H-benzo[d]imidazoles as antitubercular agents: Synthesis, biological evaluation and structure–activity relationship. Bioorganic & Medicinal Chemistry, 23(9), 2112–2120. https://doi.org/10.1016/j.bmc.2015.03.024
6. Hossain, M. I., Lee, C. I., Cho, S. J., Lee, E. S., & Park, H. J. (2013). Design, synthesis, and in vitro cancer cell growth inhibition evaluation and antimalarial testing of trioxanes installed in cyclic 2-enoate substructures. European Journal of Medicinal Chemistry, 69, 294–309. https://doi.org/10.1016/j.ejmech.2013.08.028
7. Liu, L.-X., Wang, J.-Y., Zhang, L.-L., Zhang, Y., & Zhang, Y.-Y. (2013). Synthesis and antitumor activities of novel dibenzo[b,d]furan–imidazole hybrid compounds. European Journal of Medicinal Chemistry, 66, 423–437. https://doi.org/10.1016/j.ejmech.2013.05.049
8. Martins, P., Jesus, J., Santos, S., Raposo, L. R., Roma-Rodrigues, C., Baptista, P. V., & Fernandes, A. R. (2015). Heterocyclic anticancer compounds: Recent advances and the paradigm shift towards the use of nanomedicine’s toolbox. Molecules, 20(9), 16852–16891. https://doi.org/10.3390/molecules200916852
9. Saudi, M., de Castro, C., Wardell, J. L., Wardell, S. M. S. V., & Hall, C. D. (2014). Synthesis and evaluation of imidazole-4,5- and pyrazine-2,3-dicarboxamides targeting dengue and yellow fever virus. European Journal of Medicinal Chemistry, 87, 529–539. https://doi.org/10.1016/j.ejmech.2014.10.019
10. Shalini, K., Sharma, P. K., Kumar, N., & Dudhe, R. (2010). Imidazole and its biological activities: A review. Der Chemica Sinica, 1(3), 36–47.